...
首页> 外文期刊>Journal of Nippon Medical School >Serum Cytokine Interactions Are Implicated in the Mechanism of Action of Sublingual Immunotherapy for Japanese Cedar Pollinosis
【24h】

Serum Cytokine Interactions Are Implicated in the Mechanism of Action of Sublingual Immunotherapy for Japanese Cedar Pollinosis

机译:血清细胞因子相互作用参与日本雪松花粉症舌下免疫治疗的作用机制。

获取原文
           

摘要

Objective: This study aimed to investigate whether interactions between multiple serum cytokines may be implicated in the mechanism of action (MOA) of sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. Methods: A Tokyo Metropolitan Bureau of Social Welfare and Public Health-initiated clinical study of active SLIT involving 202 patients with Japanese cedar pollinosis was jointly conducted by Tokyo Metropolitan Institute of Medical Science and Nippon Medical School between 2006 and 2008. Fifty target cytokines were quantified in serum samples collected at 6 times from baseline to the end of the study, for 300 cytokine measurements in total, using Bio-Plex Pro Human Cytokine Group I/II Panels. Therapeutic outcome was assessed based on nasal symptom scores and quality-of-life questionnaire results. Results: Fifty-five percent of patients were free of symptoms or reported symptomatic improvements by 2 grades or greater after 2 years of SLIT treatment, while 27% showed no improvement or worsening of symptoms. Thirty-eight patients who benefited the most from treatment (responders) as well as 37 patients who benefited the least from treatment (non-responders) were identified and their serum cytokine profiles were compared. Cluster analysis of the 300 cytokine measurements identified 6 cytokine clusters that were strongly correlated with a positive response to treatment, and this correlation was consistent throughout the treatment. Conclusion: Certain cytokine clusters are strongly correlated with a positive therapeutic outcome, suggesting they have a role in the MOA of immunotherapy.
机译:目的:本研究旨在探讨多种血清细胞因子之间的相互作用是否可能与日本雪松花粉症舌下免疫疗法(SLIT)的作用机制(MOA)有关。方法:2006年至2008年,由东京都医学科学研究所和日本医科大学联合开展了一项由东京市社会福利和公共卫生局发起的活动性SLIT临床研究,涉及202例日本雪松花粉症患者。该研究共定量了50种靶细胞因子。使用Bio-Plex Pro人细胞因子I / II组,从基线到研究结束6次收集的血清样品中的总样本,共进行300次细胞因子测量。根据鼻症状评分和生活质量问卷结果评估治疗结果。结果:SLIT治疗2年后,有55%的患者无症状或症状改善2级或更高,而27%的患者无症状改善或恶化。确定了38例从治疗中受益最大的患者(响应者)和37例从治疗中受益最小的患者(非响应者),并比较了他们的血清细胞因子谱。对300种细胞因子测量值进行的聚类分析确定了6种细胞因子簇,它们与对治疗的阳性反应密切相关,并且这种相关性在整个治疗过程中都是一致的。结论:某些细胞因子簇与阳性治疗结果密切相关,表明它们在免疫治疗的MOA中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号